Stock Shock

A down-on-his-luck stockbroker, desperate to make a comeback, devises a plan to short-sell the stock of a struggling pharmaceutical company. However, his scheme takes an unexpected turn when the company's experimental drug begins to have bizarre and uncontrollable side effects on the town. He must then navigate the chaos and ethical dilemmas that arise from his actions.

Stock Shock received mixed to positive reviews. Critics often praised its dark humor and satirical take on Wall Street culture and the pharmaceutical industry, though some found the plot occasionally convoluted. Audience reception was generally favorable, appreciating its unique premise and performances.

• A darkly humorous satire on corporate greed and the pharmaceutical world.

• Features strong comedic performances, particularly from the lead.

• The plot can be a bit too quirky for some viewers, but the ambition is commendable.

Google audience: Audience reviews for Stock Shock are not readily available. General consensus based on scattered online mentions suggests viewers found it an amusing if somewhat offbeat comedy with a sharp satirical edge.

The film was an independent production and had a limited theatrical release, later finding a wider audience through streaming and DVD.